Rhinitus/Sinusitis/Ocular Allergy News

Early efficacy in treatment may predict clinical response to subcutaneous immunotherapy for allergic rhinitis due to house dust mite allergy at 3 years, according to a letter published in Clinical and Translational Allergy.

SAN ANTONIO — Day two of the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting was very busy for new AAAAI president Jonathan A. Bernstein, MD, FAAAAI.

SAN ANTONIO — Nasal spray using essential oils may alleviate physical and functional impairments in allergic sinonasal-related diseases, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Patients with allergic rhinitis and comorbid asthma had poorer health-related quality of life and symptom control than patients who had allergic rhinitis alone, according to a study published in Clinical and Translational Allergy.

The presence of Charcot-Leyden crystals in nasal tissues may be used to predict the recurrence of eosinophilic chronic rhinosinusitis with nasal polyps, according to a letter published in Clinical and Translational Allergy.

Exposure to visible mold indoors was significantly associated with increased risk for current rhinitis and allergic rhinitis, with stronger associations among patients who never had asthma, according to a letter published in Allergy.

Smoking heated tobacco products during pregnancy was associated with allergy — specifically asthma, rhinitis and conjunctivitis, and atopic dermatitis — in offspring, according to a study published in Allergy.

Long-term treatment with dupilumab appeared effective among patients with asthma with or without coexisting chronic rhinosinusitis with nasal polyps, according to a study published in Annals of Allergy, Asthma & Immunology.

Researchers continued to investigate how to help allergy and asthma patients breathe easier, eat better, and live safer and more satisfying lives in 2022. Here are our top 10 stories about these developments this year.

Nearly 3 years into the pandemic, COVID-19 continues to dominate headlines and research labs as scientists explore therapies that mitigate the impact of the virus, particularly among patients with asthma and allergy.